Martin Schechter
Biographic Data
| ID | 7448975 |
|---|---|
| NAME | Martin Schechter |
| GIVEN NAMES | Martin |
| FAMILY NAME | Schechter |
| SIGNATURE | SCHECHTER M |
| AFFILIATIONS | University of British Columbia |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Navigating concurrent public health emergencies: Indigenous perspectives from the Cedar Project in British Columbia
Connection and resilience are critical to the health and wellbeing of Indigenous Peoples who use drugs (IPWUD): connection to family, cultural supports, safer coping mechanisms and circles of care. Urban IPWUD are more likely to face multiple harms from emergency public health restrictions alongside ongoing toxic drug and housing crises in British Columbia. This paper aims to amplify the experiences of urban IPWUD as they navigated the COVID-19 p…
How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives
Background Addressing inadequacies in the implementation of existing evidence-based approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative for the management of opioid use disorder. With the expansion of iOAT, stakeholder perspectives are needed to inform program optimization. This study aimed to understand stakeholder and provider perspectives on iOAT care and how it can be improved to better meet service use…
Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses
Identifying typical doses of existing opioid use disorder medications, such as injectable opioid agonist treatment (iOAT), can support client and program needs, and potentially increase iOAT expansion. Longitudinal data from participants in a cohort study ( n = 131), along with clinic dispensation records from August 2014 to April 2020, were used to examine physician prescribed as well as used doses of injectable diacetylmorphine and hydromorphon…
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)
The Cedar Project: Understanding Barriers to Consistent Condom use over Time in a Cohort of Young Indigenous People who use Drugs
Little information exists on the use of condoms as protective barriers to sexually transmitted infections (STIs) among indigenous people in Canada. This study explores risk factors of inconsistent condom use (during consensual sex) over time among participants in the Cedar Project, a prospective cohort study of indigenous young people living in Vancouver and Prince George, British Columbia, who use drugs. Due to the serial measurements for each s…
No prominent works on this page.
The Cedar Project: Understanding Barriers to Consistent Condom use over Time in a Cohort of Young Indigenous People who use Drugs
Little information exists on the use of condoms as protective barriers to sexually transmitted infections (STIs) among indigenous people in Canada. This study explores risk factors of inconsistent condom use (during consensual sex) over time among participants in the Cedar Project, a prospective cohort study of indigenous young people living in Vancouver and Prince George, British Columbia, who use drugs. Due to the serial measurements for each s…
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)
How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives
Background Addressing inadequacies in the implementation of existing evidence-based approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative for the management of opioid use disorder. With the expansion of iOAT, stakeholder perspectives are needed to inform program optimization. This study aimed to understand stakeholder and provider perspectives on iOAT care and how it can be improved to better meet service use…
Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses
Identifying typical doses of existing opioid use disorder medications, such as injectable opioid agonist treatment (iOAT), can support client and program needs, and potentially increase iOAT expansion. Longitudinal data from participants in a cohort study ( n = 131), along with clinic dispensation records from August 2014 to April 2020, were used to examine physician prescribed as well as used doses of injectable diacetylmorphine and hydromorphon…
Navigating concurrent public health emergencies: Indigenous perspectives from the Cedar Project in British Columbia
Connection and resilience are critical to the health and wellbeing of Indigenous Peoples who use drugs (IPWUD): connection to family, cultural supports, safer coping mechanisms and circles of care. Urban IPWUD are more likely to face multiple harms from emergency public health restrictions alongside ongoing toxic drug and housing crises in British Columbia. This paper aims to amplify the experiences of urban IPWUD as they navigated the COVID-19 p…
HIV, Drug Use, Sexual Risk (4 works) · Medicine (4 works) · Opioid Use Disorder Treatment (3 works) · Political science (3 works) · Sociology (3 works) · Business (2 works) · Cohort (2 works) · Focus group (2 works) · Hydromorphone (2 works) · Indigenous (2 works)